Reports are generated and provided to the 340B Entity on a semi-monthly basis. The initial Reporting Period will consist of fifteen calendars days commencing on the Pharmacy Service Agreement start date. The second reporting period will begin on the sixteenth calendar days after the contractual start date. Each subsequent semi-monthly reporting period will begin on the 1st of each month and the 16th of each month.

Our 340B Administration Support Team will provide Covered Entities with reports for the prior semi-monthly Reporting Period within 5 business days after the commencement of each semi-monthly Reporting Period. Additional ad-hoc reports can also be generated as needed at the request of the Covered Entity.

In relation to the HIPAA Privacy Rule and the HIPAA Security Rule, data encryption is a  method to safeguard protected health information (PHI). To make sure the delivery of reports is HIPAA compliant we use end-to-end encryption, which secures both messages in transit and stored messages. This allows us to safely deliver reports and data containing PHI. Our 340B support team will contact your team for initial training and set up.

The Inventory Report details the total quantity of each Covered Drug dispensed and replenished by drug name, strength, NDC, quantity dispensed to Eligible Patients, quantity replenished, date of replenishment, quantity returned, and balance of each Covered Drug in units and aggregate value based on purchase price.

Covered Entity will be provided with 340B statements that totals, in aggregate and by payer source, gross reimbursements due to entity, cash collected on behalf of entity, total costs of goods sold, total number of dispenses, total dispensing fees to be paid to pharmacy, and net cash income earned by Entity (collections minus cost of goods sold minus fees), for the reporting period.